Clovis Oncology (CLVS) Stock Rallies On Buyout Rumors
Shares of Clovis Oncology (NASDAQ:CLVS) are up 25% today on rumors that the cancer treatment company could be acquired by pharmaceutical giant Sanofi (NASDAQ:SNY). The movement in CLVS stock… Read More »Clovis Oncology (CLVS) Stock Rallies On Buyout Rumors